Impact of cannabis knowledge and attitudes on real-world practice

Background: Increased cannabis consumption worldwide challenges allergists because of an upsurge in canna-bis allergy and need to discuss cannabis with patients.Objective: To determine the knowledge, attitudes, and practices regarding cannabis among allergists and their approach to recognizing and diagnosing suspected cannabis allergy.Methods: The International Allergist Canna Knowledge, Attitudes, and Practices Survey was completed by mem-bers from 3 International Allergy Societies. Survey questions included the following: 13 on cannabis attitudes, 7 on cannabis knowledge, and 4 on real-world allergy practices. Knowledge level was dichotomized and Statisti-cal Package for the Social Sciences TwoStep Cluster Analysis grouped participants by attitudes. Multivariate anal-ysis determined the relationship of knowledge and attitude to practice delivery.Results: Of 570 eligible surveys started, 445 (78.1%) were completed. Participants were 49.7% of female sex, 65.9% aged 24 to 56 years, approximately 70% in practice for more than or equal to 10 years, and 29.2% practicing in an area where cannabis use is illegal. Of the respondents, 43.1% reported consulting on patients with sus-pected cannabis allergy and 54.7% had undertaken skin prick testing, in vitro cannabis testing, or both. Statisti-cally significant differences were found between the 3 societies for most variables analyzed. Analysis of attitudes revealed 3 clusters named Traditional, Progressive, and Unsure. Those with more progressive attitudes toward cannabis and who had more knowledge were more comfortable speaking to patients about cannabis and more often asked patients on how often and how they used cannabis (all P < .001).Conclusion: Varying knowledge and attitudes toward cannabis affecting comfort communicating with patients about cannabis were found in members of 3 allergy societies supporting the need for more cannabis research and education.Crown Copyright (c) 2022. Published by Elsevier Inc. on behalf of American College of Allergy, Asthma & Immunology.